Seven Eight Capital’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-5,800
Closed -$140K 784
2014
Q2
$140K Buy
+5,800
New +$60.5K 0.14% 246

Seven Eight Capital's IDIX Position: Q3 2014 in Review

Seven Eight Capital sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 5,800 shares — an estimated $140K sold.

Seven Eight Capital first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $140K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Seven Eight Capital reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Seven Eight Capital sold 5,800 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $140K.
  • Seven Eight Capital first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Seven Eight Capital's IDENIX PHARMACEUTICALS INC position peaked at $140K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Seven Eight Capital's 13F filing for Q3 2014, filed 13 Nov 2014.